1
|
Kadara H, Kabbout M and Wistuba II:
Pulmonary adenocarcinoma: a renewed entity in 2011. Respirology.
17:50–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Travis WD, Brambilla E, Noguchi M, et al;
American Thoracic Society. International Association for the Study
of Lung Cancer/American Thoracic Society/European Respiratory
Society: international multidisciplinary classification of lung
adenocarcinoma: executive summary. Proc Am Thorac Soc. 8:381–385.
2011. View Article : Google Scholar
|
3
|
Hodkinson PS and Sethi T: Advances in the
prevention and treatment of lung cancer. J R Coll Physicians Edinb.
41:142–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mitsudomi T and Yatabe Y: Mutations of the
epidermal growth factor receptor gene and related genes as
determinants of epidermal growth factor receptor tyrosine kinase
inhibitors sensitivity in lung cancer. Cancer Sci. 98:1817–1824.
2007. View Article : Google Scholar
|
5
|
de Mello RA, Marques DS, Medeiros R and
Araújo AM: Epidermal growth factor receptor and K-Ras in non-small
cell lung cancer-molecular pathways involved and targeted
therapies. World J Clin Oncol. 2:367–376. 2011.PubMed/NCBI
|
6
|
Moran C: Importance of molecular features
of non-small cell lung cancer for choice of treatment. Am J Pathol.
178:1940–1948. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Patiar S and Harris AL: Role of
hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr
Relat Cancer. 13(Suppl 1): S61–S75. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Savai R, Schermuly RT, Voswinckel R, et
al: HIF-1α attenuates tumor growth in spite of augmented
vascularization in an A549 adenocarcinoma mouse model. Int J Oncol.
27:393–400. 2005.
|
9
|
Scortegagna M, Martin RJ, Kladney RD,
Neumann RG and Arbeit JM: Hypoxia-inducible factor-1alpha
suppresses squamous carcinogenic progression and
epithelial-mesenchymal transition. Cancer Res. 69:2638–2646. 2009.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Sinha I, Null K, Wolter W, et al:
Methylseleninic acid downregulates hypoxia-inducible factor-1α in
invasive prostate cancer. Int J Cancer. 130:1430–1439.
2012.PubMed/NCBI
|
11
|
Wan J, Chai H, Yu Z, et al: HIF-1α effects
on angiogenic potential in human small cell lung carcinoma. J Exp
Clin Cancer Res. 30:772011.
|
12
|
Hannon GJ: RNA interference. Nature.
418:244–251. 2002. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Volm M and Koomägi R: Hypoxia-inducible
factor (HIF-1) and its relationship to apoptosis and proliferation
in lung cancer. Anticancer Res. 20:1527–1533. 2000.PubMed/NCBI
|
14
|
Swinson DE, Jones JL, Cox G, et al:
Hypoxia-inducible factor-1 alpha in non small cell lung cancer:
relation to growth factor, protease and apoptosis pathways. Int J
Cancer. 111:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Shyu KG, Hsu FL, Wang MJ, Wang BW and Lin
S: Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma
cell invasion. Exp Cell Res. 313:1181–1191. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Luo F, Liu X, Yan N, et al:
Hypoxia-inducible transcription factor-1alpha promotes
hypoxia-induced A549 apoptosis via a mechanism that involves the
glycolysis pathway. BMC Cancer. 6:262006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Liao HY, Wang GP, Gu LJ, et al: HIF-1α
siRNA and cisplatin in combination suppress tumor growth in a nude
mice model of esophageal squamous cell carcinoma. Asian Pac J
Cancer Prev. 13:473–477. 2012.
|
18
|
Wang G, Ye Y, Yang X, Liao H, Zhao C and
Liang S: Expression-based in silico screening of candidate
therapeutic compounds for lung adenocarcinoma. PLoS One.
6:e145732011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Xu K, Ding Q, Fang Z, et al: Silencing of
HIF-1alpha suppresses tumorigenicity of renal cell carcinoma
through induction of apoptosis. Cancer Gene Ther. 17:212–222. 2010.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Kurokawa T, Miyamoto M, Kato K, et al:
Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in
oesophageal squamous cell carcinoma correlates with lymph node
metastasis and pathologic stage. Br J Cancer. 89:1042–1047. 2003.
View Article : Google Scholar
|
21
|
Theodoropoulos GE, Lazaris AC,
Theodoropoulos VE, et al: Hypoxia, angiogenesis and apoptosis
markers in locally advanced rectal cancer. Int J Colorectal Dis.
21:248–257. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Flamant L, Notte A, Ninane N, Raes M and
Michiels C: Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel
exposed breast cancer cells under hypoxia. Mol Cancer. 9:1912010.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Yook YJ, Seo YJ, Kang HJ, et al: Induction
of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in
the human leukemic cell line HL-60. Korean J Hematol. 45:158–163.
2010.
|
24
|
Olsson M and Zhivotovsky B: Caspases and
cancer. Cell Death Differ. 18:1441–1449. 2011. View Article : Google Scholar
|